Monthly Multi-Institutional Hematopathology Interesting Case Conference
The Multi-Institutional Hematopathology Interesting Case Conference (MHICC) is a monthly virtual CME meeting to provide a platform for oncologists, pathologists, and trainees from leading institutions across North America to collaboratively discuss complex and educational hematopathology cases. This interactive and case-based discussion forum offers a unique opportunity to engage with experts, review complex cases, and strengthen interdisciplinary collaboration in hematopathology.
View Participating Institutions
Schedule for 2025 MHICC
| Date | Presenting Institution |
|---|---|
| February 26 | FCCC |
| March 19 | Mount Sinai |
| April 23 | MSKCC |
| May 28 | Cleveland Clinic |
| June 25 | Weill Cornell Medical College |
| August 27 | University of Toronto |
| September 24 | University of Pennsylvania |
| October 22 | NYU |
| November 19 | Mass General Brigham |
| December 17 | Emory University |
Upcoming Session
Date: Wednesday, December 17, 2025
Time: 5:00PM (EST)
Presenting Institution: Emory University
To Access the Meeting:
- Click here
- Sign-in with your EMAIL and click “Next”
- Enter your personal information requested and click “Sign in Now”
- Click “Watch this Lecture Remotely” to enter the meeting
Cases:
Case 1: 43-year-old male with a 10-year history of waxing and waning generalized rash, refractory to multiple treatments, including topical and systemic steroids. A skin biopsy and a subsequent bone marrow biopsy was performed.
Case Pathology Slides: CD2, CD7, Bone Marrow (H&E), Skin (H&E)
Case 2: A 33-year-old male presented with sore throat, posterior oropharyngeal erythema, and cervical lymphadenopathy. Imaging revealed a large exophytic pharyngeal mass with intense FDG uptake and hypermetabolic right axillary and right upper-lobe lesions, highly concerning for metastatic squamous cell carcinoma.
Case Pathology Slides: CD20, TDT, PAX5, CD10, Tonsils (H&E), CD34
Case 3: A 56-year-old man with stage IIIA follicular lymphoma on observation since 2005 presented with rapidly enlarging, FDG-avid bilateral cervical lymphadenopathy and tonsillar enlargement.
Case Pathology Slides: PAX5, BCL6, CD163, BCL2, Lymph node (H&E)
Click here to view previous MHICC Cases and Presentations
Educational Objectives:
By participating in this monthly conference, attendees will be able to:
- Discuss key concepts related to hematopathology including flow cytometry, broadly-defined molecular, cytogenetic and clinical findings as well as therapeutic implications.
- Identify and analyze challenging hematologic neoplasms, applying updated diagnostic criteria and emerging recommendations to improve patient outcome.
- Integrate novel diagnostic modalities and recent advancements in hematopathology to enhance diagnostic accuracy and facilitate more precise clinical decision-making.
Target Audience:
The MHICC is designed for a diverse audience of healthcare professionals with an interest in hematopathology and related fields. This includes, but is not limited to:
- Pathologists, as well as Medical and Radiation Oncologists
- Fellows, Residents, and Trainees in Pathology, Hematopathology, Molecular Pathology, Hematologic Oncology, and Radiation Oncology
Participating Institutions and Organizing Committee Members:
Cleveland Clinic - Megan Nakashima, MD and Anna B. Owczarczyk, MD, PhD
Emory University - Brooj Abro, MD and David L. Jaye, MD
Fox Chase Cancer Center - Nicholas Mackrides, MD; Mariusz Wasik, MD; Reza Nejati, MD; Rashmi Khanal, MD and Anthony Stack, DO
Icahn School of Medicine at Mount Sinai - Shafinaz Hussein, MD
Mass General Brigham - Sam Sadigh, MD
Memorial Sloan Kettering Cancer Center - Pallavi Kanwar, MD and Alexander Chan, MD
National Institutes of Health (NIH) - Katherine Calvo, MD, PhD
NYU Grossman School of Medicine - Nicholas Ward, MD
University of Pennsylvania - Siddharth Bhattacharyya, MD
University of Toronto - Ali Sakhdari, MD
Weill Cornell Medicine - Sanjay Patel, MD
For more information, please contact Reza Nejati, MD, Chair of the Organizing Committee, at Reza.Nejati@fccc.edu.
CME Information and Credit Instructions
To Access your CME Certificate:
After the meeting, you’ll receive an email prompting you to complete a brief evaluation. Once submitted, your credit certificate will be available for download—please remember to save it for your records.
Accreditation Statement:
Temple Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
Credit Designation:
Temple Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.
If you have any questions regarding CME credits, please don’t hesitate to reach out to Lucía Tono at Lucia.Tono-Ramirez@tuhs.temple.edu.